abstract |
The present invention provides methods of determining aggregation of alpha-synuclein, which are a hallmark of Lewy body diseases such as Parkinson's disease. Also disclosed are inhibitors of the aggregation, including magnesium and alpha-synuclein binding peptides. The inhibitors are useful in the treatment of Lewy body diseases. |